Tracy Sexton
University of Western Ontario
19 Papers
84 Citations
Tracy Sexton is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 6, co-authored 19 publications. Previous affiliations of Tracy Sexton include London Health Sciences Centre.
Chat about Author
Papers
A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer
Glenn Bauman,Michelle Ferguson,Michael Lock,Jeff Chen,Belal Ahmad,Varagur Venkatesan,Tracy Sexton,David D'Souza,Andrew Loblaw,Andrew Warner,George Rodrigues +10 more
TL;DR: This novel condensed treatment had higher than anticipated late toxicities and was terminated before phase 2 accrual.
69
Technology assessment of automated atlas based segmentation in prostate bed contouring
J. Hwee,Alexander V. Louie,Stewart Gaede,Glenn Bauman,David D'Souza,Tracy Sexton,Michael Lock,Belal Ahmad,George Rodrigues +8 more
TL;DR: The AABS tool results in a time savings, and when used to generate auto-contours for the femoral heads, bladder and rectum had superior to good spatial overlap, however, the generated auto- Contour for the prostate bed and penile bulb need improvement.
A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer.
Michael Lock,Lara Best,Eugene Wong,Glenn Bauman,David D'Souza,Varagur Venkatesan,Tracy Sexton,Belal Ahmad,Jonathan I. Izawa,George Rodrigues +9 more
TL;DR: Hypofractionated simplified intensity-modulated arc therapy radiotherapy given as 63.2 Gy in 20 fractions demonstrated promising biochemical control rates; however, higher rates of acute Grade 3 GU andGI toxicity and higher late Grade 2 GU and GI toxicity were noted.
38
The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy.
Lori E. Lowes,Lori E. Lowes,Michael Lock,Michael Lock,George Rodrigues,George Rodrigues,David D'Souza,David D'Souza,Glenn Bauman,Glenn Bauman,Belal Ahmad,Belal Ahmad,Varagur Venkatesan,Varagur Venkatesan,Alison L. Allan,Alison L. Allan,Tracy Sexton,Tracy Sexton +17 more
TL;DR: The results suggest that CTCs may be indicative of disseminated disease and assessment of C TCs during RT may be helpful in clinical decision-making to determine, which patients may benefit from RT versus those who may benefit more from systemic treatments.
30
A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis.
Laura Callan,Glenn Bauman,Jeff Chen,Michael Lock,Tracy Sexton,David D'Souza,George Rodrigues +6 more
TL;DR: FASTR-2, which used a lower dose to the prostate, smaller posterior PTV margin and omitted nodal radiation to lower the volumes of rectum receiving high and intermediate doses compared with FASTR, is presented.
20